C4 Therapeutics (CCCC) Other Non-Current Assets (2019 - 2025)
Historic Other Non-Current Assets for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $3.4 million.
- C4 Therapeutics' Other Non-Current Assets changed 0.0% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.4 million for FY2024, which is 0.0% changed from last year.
- As of Q3 2025, C4 Therapeutics' Other Non-Current Assets stood at $3.4 million, which was down 0.0% from $3.4 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Other Non-Current Assets ranged from a high of $3.5 million in Q3 2023 and a low of $1.3 million during Q2 2021
- In the last 5 years, C4 Therapeutics' Other Non-Current Assets had a median value of $3.3 million in 2021 and averaged $3.1 million.
- Per our database at Business Quant, C4 Therapeutics' Other Non-Current Assets tumbled by 5048.51% in 2021 and then surged by 15697.49% in 2022.
- Over the past 5 years, C4 Therapeutics' Other Non-Current Assets (Quarter) stood at $3.3 million in 2021, then changed by 0.0% to $3.3 million in 2022, then increased by 5.0% to $3.4 million in 2023, then changed by 0.0% to $3.4 million in 2024, then changed by 0.0% to $3.4 million in 2025.
- Its Other Non-Current Assets was $3.4 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.4 million in Q1 2025.